- Patent Title: Implantable fluid management system for the removal of excess fluid
-
Application No.: US15220812Application Date: 2016-07-27
-
Publication No.: US09913968B2Publication Date: 2018-03-13
- Inventor: Daniel R. Burnett
- Applicant: Sequana Medical AG
- Applicant Address: CH Zug
- Assignee: Sequana Medical AG
- Current Assignee: Sequana Medical AG
- Current Assignee Address: CH Zug
- Agency: Foley & Lardner LLP
- Agent Christopher C. Bolten; Nicola A. Pisano
- Main IPC: A61M5/00
- IPC: A61M5/00 ; A61M27/00 ; A61M5/142 ; A61M39/24 ; A61M1/28 ; A61M5/172

Abstract:
An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.
Public/Granted literature
- US20160331947A1 IMPLANTABLE FLUID MANAGEMENT SYSTEM FOR THE REMOVAL OF EXCESS FLUID Public/Granted day:2016-11-17
Information query
IPC分类: